111 related articles for article (PubMed ID: 10648079)
1. Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma.
Ishida T
Surg Today; 2000; 30(1):28-32. PubMed ID: 10648079
[TBL] [Abstract][Full Text] [Related]
2. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
[TBL] [Abstract][Full Text] [Related]
4. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer.
Nihei Z; Ichikawa W; Kojima K; Togo S; Miyanaga T; Hirayama R; Mishima Y
Surg Today; 1996; 26(9):760-1. PubMed ID: 8883258
[TBL] [Abstract][Full Text] [Related]
5. [Expression of CD44 standard and CD44 variant 6 in human lung cancer].
Ochiai S; Nakanishi Y; Mizuno K; Hashimoto S; Inutsuka S; Kawasaki M; Yatsunami J; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1179-85. PubMed ID: 9493443
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
[TBL] [Abstract][Full Text] [Related]
7. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
[TBL] [Abstract][Full Text] [Related]
8. [Expression of CD44 isoforms--a new histopathologic parameter in colorectal carcinoma?].
Finke LH; Zörb C; Haensch W; Schlag PM; Terpe HJ
Zentralbl Chir; 1996; 121(6):450-4. PubMed ID: 8767329
[TBL] [Abstract][Full Text] [Related]
9. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
11. [Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance].
Chai LX; Sun KL; Guo LP; Zhang HT; Lu SX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):685-8. PubMed ID: 18246799
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.
Ayhan A; Tok EC; Bildirici I; Ayhan A
Gynecol Oncol; 2001 Mar; 80(3):355-8. PubMed ID: 11263931
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 in human neoplastic and normal hyaline cartilage.
Bosch PP; Stevens JW; Noonan KJ; Buckwalter JA; Midura RJ
Iowa Orthop J; 2002; 22():47-54. PubMed ID: 12180611
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells.
Orzechowski HD; Beckenbach C; Herbst H; Stölzel U; Riecken EO; Stallmach A
Eur J Cancer; 1995 Nov; 31A(12):2073-9. PubMed ID: 8562168
[TBL] [Abstract][Full Text] [Related]
15. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
16. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma.
Jang KS; Song YS; Jang SH; Min KW; Na W; Jang SM; Jun YJ; Lee KH; Choi D; Paik SS
Histopathology; 2010 Jan; 56(2):229-39. PubMed ID: 20102402
[TBL] [Abstract][Full Text] [Related]
18. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
